Market Closed -
Australian S.E.
02:10:45 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
14.57
AUD
|
-2.80%
|
|
+1.32%
|
-8.94%
|
Fiscal Period: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,649
|
1,267
|
1,517
|
733.7
|
883.5
|
730.1
|
-
|
-
|
Enterprise Value (EV)
1 |
1,595
|
1,201
|
1,434
|
612.2
|
726.6
|
543.3
|
510.6
|
472.2
|
P/E ratio
|
92
x
|
77.7
x
|
63.4
x
|
36.8
x
|
30.3
x
|
21.3
x
|
19.7
x
|
17.2
x
|
Yield
|
0.07%
|
0.1%
|
0.08%
|
0.27%
|
0.28%
|
0.46%
|
0.51%
|
0.63%
|
Capitalization / Revenue
|
53.1
x
|
38.9
x
|
31.6
x
|
11.2
x
|
11.3
x
|
8.16
x
|
7.4
x
|
6.48
x
|
EV / Revenue
|
51.4
x
|
36.9
x
|
29.9
x
|
9.32
x
|
9.28
x
|
6.07
x
|
5.18
x
|
4.19
x
|
EV / EBITDA
|
90.4
x
|
92.2
x
|
55
x
|
16.4
x
|
19.5
x
|
12.4
x
|
10.4
x
|
8.34
x
|
EV / FCF
|
87.6
x
|
90.3
x
|
77.9
x
|
15.5
x
|
20.2
x
|
15
x
|
12.6
x
|
9.62
x
|
FCF Yield
|
1.14%
|
1.11%
|
1.28%
|
6.44%
|
4.94%
|
6.65%
|
7.94%
|
10.4%
|
Price to Book
|
-
|
-
|
15.4
x
|
5.84
x
|
5.37
x
|
3.85
x
|
3.31
x
|
2.87
x
|
Nbr of stocks (in thousands)
|
48,961
|
49,410
|
49,410
|
49,410
|
49,410
|
50,108
|
-
|
-
|
Reference price
2 |
33.68
|
25.65
|
30.70
|
14.85
|
17.88
|
14.57
|
14.57
|
14.57
|
Announcement Date
|
8/28/19
|
8/26/20
|
8/26/21
|
8/30/22
|
8/29/23
|
-
|
-
|
-
|
Fiscal Period: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
31.05
|
32.56
|
47.98
|
65.72
|
78.32
|
89.47
|
98.61
|
112.7
|
EBITDA
1 |
17.64
|
13.03
|
26.1
|
37.44
|
37.2
|
43.78
|
49.01
|
56.6
|
EBIT
1 |
17.55
|
12.6
|
25.24
|
36.68
|
36.41
|
42.75
|
47.55
|
55.24
|
Operating Margin
|
56.53%
|
38.69%
|
52.61%
|
55.82%
|
46.49%
|
47.78%
|
48.22%
|
49.04%
|
Earnings before Tax (EBT)
1 |
18.11
|
13.14
|
25.71
|
34.32
|
45.58
|
50.58
|
54.68
|
59.58
|
Net income
1 |
18.13
|
16.65
|
24.73
|
20.88
|
30.6
|
34.71
|
37.47
|
42.84
|
Net margin
|
58.41%
|
51.12%
|
51.54%
|
31.77%
|
39.08%
|
38.8%
|
38%
|
38.02%
|
EPS
2 |
0.3660
|
0.3300
|
0.4840
|
0.4030
|
0.5910
|
0.6853
|
0.7411
|
0.8475
|
Free Cash Flow
1 |
18.2
|
13.3
|
18.41
|
39.44
|
35.88
|
36.13
|
40.57
|
49.07
|
FCF margin
|
58.61%
|
40.84%
|
38.37%
|
60.01%
|
45.82%
|
40.39%
|
41.14%
|
43.55%
|
FCF Conversion (EBITDA)
|
103.16%
|
102.09%
|
70.53%
|
105.33%
|
96.45%
|
82.53%
|
82.78%
|
86.7%
|
FCF Conversion (Net income)
|
100.35%
|
79.89%
|
74.44%
|
188.89%
|
117.25%
|
104.1%
|
108.25%
|
114.54%
|
Dividend per Share
2 |
0.0250
|
0.0250
|
0.0250
|
0.0400
|
0.0500
|
0.0675
|
0.0747
|
0.0914
|
Announcement Date
|
8/28/19
|
8/26/20
|
8/26/21
|
8/30/22
|
8/29/23
|
-
|
-
|
-
|
Fiscal Period: Juni |
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
13.63
|
34.34
|
-
|
41.09
|
-
|
48.97
|
32.26
|
53.9
|
EBITDA
1 |
5.613
|
20.49
|
9.847
|
27.71
|
14.91
|
22.3
|
13.74
|
33.3
|
EBIT
1 |
5.613
|
19.62
|
9.455
|
27.35
|
14.53
|
21.88
|
13.16
|
33.3
|
Operating Margin
|
41.17%
|
57.14%
|
-
|
66.56%
|
-
|
44.69%
|
40.8%
|
61.78%
|
Earnings before Tax (EBT)
1 |
5.811
|
19.9
|
8.726
|
25.6
|
14.6
|
30.98
|
14.81
|
37.3
|
Net income
1 |
6.487
|
18.24
|
5.87
|
15.01
|
11.39
|
19.22
|
10.94
|
24.9
|
Net margin
|
47.58%
|
53.11%
|
-
|
36.52%
|
-
|
39.25%
|
33.9%
|
46.2%
|
EPS
2 |
0.1270
|
0.3570
|
0.1140
|
0.2890
|
0.2200
|
0.3710
|
0.2120
|
0.4930
|
Dividend per Share
2 |
-
|
0.0250
|
-
|
0.0400
|
-
|
0.0500
|
-
|
0.0700
|
Announcement Date
|
2/23/21
|
8/26/21
|
2/22/22
|
8/30/22
|
2/23/23
|
8/29/23
|
2/21/24
|
-
|
Fiscal Period: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
54.3
|
66.7
|
82.7
|
122
|
157
|
187
|
219
|
258
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
18.2
|
13.3
|
18.4
|
39.4
|
35.9
|
36.1
|
40.6
|
49.1
|
ROE (net income / shareholders' equity)
|
32%
|
-
|
28.7%
|
18.6%
|
19%
|
18.8%
|
17.4%
|
17.3%
|
ROA (Net income/ Total Assets)
|
34.5%
|
23.1%
|
26%
|
16.5%
|
18.1%
|
15.4%
|
14.6%
|
13.9%
|
Assets
1 |
52.62
|
71.94
|
95.05
|
126.3
|
168.8
|
225.7
|
256.6
|
308.6
|
Book Value Per Share
2 |
-
|
-
|
2.000
|
2.540
|
3.330
|
3.790
|
4.400
|
5.070
|
Cash Flow per Share
2 |
0.3700
|
0.2800
|
0.3800
|
0.7700
|
0.7100
|
0.8300
|
0.8400
|
0.9800
|
Capex
1 |
0.26
|
0.89
|
0.85
|
0.43
|
1.03
|
6.08
|
2.73
|
1.53
|
Capex / Sales
|
0.83%
|
2.73%
|
1.78%
|
0.66%
|
1.31%
|
6.79%
|
2.77%
|
1.36%
|
Announcement Date
|
8/28/19
|
8/26/20
|
8/26/21
|
8/30/22
|
8/29/23
|
-
|
-
|
-
|
Last Close Price
14.57
AUD Average target price
25.6
AUD Spread / Average Target +75.72% Consensus |
1st Jan change
|
Capi.
|
---|
| -8.94% | 476M | | -4.66% | 86.13B | | +1.32% | 39.82B | | -19.27% | 30.42B | | +57.86% | 25.23B | | -17.69% | 11.6B | | -43.00% | 11.51B | | -9.14% | 11.95B | | +5.24% | 8.71B | | -8.42% | 8.12B |
Biopharmaceuticals
|